---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-060937"
form_type: "8-K"
ticker: null
cik: "0001769759"
company_name: "Monogram Technologies Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T01:03:20.754265+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Monogram Orthopaedics Q1 net loss $3.5M; 510(k) submission on track for H2 2024

## Summary
- Net loss $3.5M in Q1 2024 vs $3.9M prior year; cash $10.1M at Mar 31.
- Verification & validation testing expected largely complete in Q2 2024.
- FDA 510(k) submission for mBôs TKA system planned for second half of 2024.
- Engaged contract research organization for OUS clinical trial activities.
- R&D expenses $2.4M, up from $1.9M, driven by V&V and mVision development.

## SEC filing metadata
- accession: 0001104659-24-060937
- form_type: 8-K
- cik: 0001769759
- company_name: Monogram Technologies Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1769759/000110465924060937/0001104659-24-060937-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1769759/000110465924060937/tm2414401d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-060937
- JSON: https://secwatch.observer/filing/0001104659-24-060937.json
- Plain text: https://secwatch.observer/filing/0001104659-24-060937.txt

## Key facts
- Earnings Releases
  Monogram Technologies Inc. reported the first quarter ended March 31, 2024 results: net income Net loss was $3.5 million.
  - Period: the first quarter ended March 31, 2024
  - Net income: Net loss was $3.5 million
  - Result: reported results
  source text: On May 14, 2024, Monogram Orthopaedics Inc., a Delaware corporation (the “Company”) issued a press release announcing, among other things, its financial results for the three months ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1769759/000110465924060937/0001104659-24-060937-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.